Skip to main content
Clinical Trials/DRKS00026926
DRKS00026926
Recruiting
Not Applicable

Influence of therapeutic drug monitoring (TDM) on the tolerability and efficacy of 5-FU-containing chemotherapy in patients with colorectal carcinoma in the colorectal center at St.-Franziskus-Hospital Münster: a prospective, monocentric observational study. - 5FU-TDM

St. Franziskus-Hospital GmbH0 sites50 target enrollmentOctober 18, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C18
Sponsor
St. Franziskus-Hospital GmbH
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with stage II and III colon cancer for whom adjuvant chemotherapy is indicated and planned according to the FOLFOX4 regimen.
  • \- Patients with stage IV colon cancer in whom palliative or conversion chemotherapy according to the FOLFOX4 \+/\- bevacizumab regimen is indicated and planned.

Exclusion Criteria

  • Non\-consenting adults,
  • Pregnant and breastfeeding women

Outcomes

Primary Outcomes

Not specified

Similar Trials